Surface modification of nonviral nanocarriers for enhanced gene delivery

Nanomedicine

Volumn 9, Issue 1, 2014, Pages 135-151

  Fortier, Charles ^a,b   Durocher, Yves ^a   De Crescenzo, Gregory ^b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

Author keywords

biofunctionalization; lateral stabilization; nonviral gene delivery; polymeric coating; responsive tethering; shielding; surface modification

Indexed keywords

NANOCARRIER; NANOCOATING; NONVIRAL NANOCARRIER; SMALL INTERFERING RNA; TRANSFERRIN; UNCLASSIFIED DRUG;

CELL ADHESION; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CELL SURFACE; CONFORMATIONAL TRANSITION; CONJUGATION; CROSS LINKING; ENDOSOMAL ESCAPE; ENDOSOME; ERYTHROCYTE MEMBRANE; GENE SILENCING; HALF LIFE TIME; HUMAN; KUPFFER CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE COMPLEX; PRIORITY JOURNAL; REVIEW; STATIC ELECTRICITY; SURFACE CHARGE; SURFACE COATING; SURFACE FORMATION; SURFACE MODIFICATION; SURFACE PROPERTY; TARGET CELL;

GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; SURFACE PROPERTIES;

EID: 84896506823     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.194     Document Type: Review

References (88)

1. Glover DJ, Lipps HJ, Jans DA. Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev. Genet. 6(4), 299-310 (2005).
2. Mueller C, Flotte TR. Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther. 15(11), 858-863 (2008).
3. Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat. Rev. Drug Discov. 4(7), 581-593 (2005).
4. Nel AE, Madler L, Velegol D et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8(7), 543-557 (2009).
5. Salvati A, Pitek AS, Monopoli MP et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 8(2), 137-143 (2013).
6. Kasper JC, Troiber C, Kuchler S, Wagner E, Friess W. Formulation development of lyophilized, long-term stable siRNA/oligoaminoamide polyplexes. Eur. J. Pharm. Biopharm. 85(2), 294-305 (2013).
7. Mandal B, Bhattacharjee H, Mittal N et al. Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform. Nanomed. Nanotechnol. 9(4), 474-491 (2013).
8. Fortier C, De Crescenzo G, Durocher Y. A versatile coiled-coil tethering system for the oriented display of ligands on nanocarriers for targeted gene delivery. Biomaterials 34(4), 1344-1353 (2013).
9. Roy R, Jerry DJ, Thayumanavan S. Virus-inspired approach to nonviral gene delivery vehicles. Biomacromolecules 10(8), 2189-2193 (2009).
10. Gajbhiye V, Gong S. Lectin functionalized nanocarriers for gene delivery. Biotechnol. Adv. 31(5), 552-562 (2013).
11. Wijagkanalan W, Kawakami S, Hashida M. Glycosylated carriers for cell-selective and nuclear delivery of nucleic acids. Front. Biosci. 16, 2970-2987 (2011).
12. Schäfer A, Pahnke A, Schaffert D et al. Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation. Hum. Gene Ther. 22, 1463-1473 (2011).
13. Liu M, Li ZH, Xu FJ et al. An oligopeptide ligand-mediated therapeutic gene nanocomplex for liver cancer-targeted therapy. Biomaterials 33(7), 2240-2250 (2011).
14. Liu C, Liu F, Feng L, Li M, Zhang J, Zhang N. The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. Biomaterials 34(10), 2547-2564 (2013).
15. Shen M, Gong F, Pang P et al. An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma. Int. J. Nanomed. 7, 3319-3332 (2012).
16. Fella C, Walker GF, Ogris M, Wagner E. Amine-reactive pyridylhydrazone-based PEG reagents for pH-reversible PEI polyplex shielding. Eur. J. Pharm. Sci. 34(4-5), 309-320 (2008).
17. Zhang X, Pan SR, Hu HM et al. Poly(ethylene glycol)-block- polyethylenimine copolymers as carriers for gene delivery: effects of PEG molecular weight and PEGylation degree. J. Biomed. Mater. Res. A 84(3), 795-804 (2008).
18. Erbacher P, Bettinger T, Belguise-Valladier P et al. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J. Gene Med. 1(3), 210-222 (1999).
19. Fitzsimmons RE, Uludag H. Specific effects of PEGylation on gene delivery efficacy of polyethylenimine: interplay between PEG substitution and N/P ratio. Acta Biomater. 8(11), 3941-3955 (2012).
20. Mao S, Neu M, Germershaus O et al. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/siRNA polyplexes. Bioconjug. Chem. 17(5), 1209-1218 (2006).
21. Zhu L, Kate P, Torchilin VP. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. ACS Nano 6(4), 3491-3498 (2012).
22. Nakamura K, Yamashita K, Itoh Y, Yoshino K, Nozawa S, Kasukawa H. Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods. Biochim. Biophys. Acta 1818(11), 2801-2807 (2012).
23. Kuai R, Yuan W, Li W et al. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration. Mol. Pharm. 8(6), 2151-2161 (2011).
24. Ishitsuka T, Akita H, Harashima H. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung. J. Control. Release 154(1), 77-83 (2011).
25. Peeters L, Sanders NN, Jones A, Demeester J, De Smedt SC. Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells. J. Control. Release 121(3), 208-217 (2007).
26. Shim MS, Kim CS, Ahn YC, Chen Z, Kwon YJ. Combined multimodal optical imaging and targeted gene silencing using stimuli-transforming nanotheragnostics. J. Am. Chem. Soc. 132(24), 8316-8324 (2010).
27. Banerjee D, Liu AP, Voss NR, Schmid SL, Finn MG. Multivalent display and receptor-mediated endocytosis of transferrin on virus-like particles. ChemBioChem 11(9), 1273-1279 (2010).
28. Amoozgar Z, Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4(2), 219-233 (2012).
29. Romberg B, Oussoren C, Snel CJ, Carstens MG, Hennink WE, Storm G. Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration. Biochim. Biophys. Acta 1768(3), 737-743 (2007).
30. Fakhari A, Baoum A, Siahaan TJ, Le KB, Berkland C. Controlling ligand surface density optimizes nanoparticle binding to ICAM-1. J. Pharm. Sci. 100(3), 1045-1056 (2011).
31. Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond.) 6(4), 715-728 (2011).
32. Laga R, Carlisle R, Tangney M, Ulbrich K, Seymour LW. Polymer coatings for delivery of nucleic acid therapeutics. J. Control. Release 161(2), 537-553 (2012).
33. Oupicky D, Ogris M, Howard KA, Dash PR, Ulbrich K, Seymour LW. Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol. Ther. 5(4), 463-472 (2002).
34. Harris TJ, Green JJ, Fung PW, Langer R, Anderson DG, Bhatia SN. Tissue-specific gene delivery via nanoparticle coating. Biomaterials 31(5), 998-1006 (2010).
35. Honig D, Derouchey J, Jungmann R, Koch C, Plank C, Radler JO. Biophysical characterization of copolymer-protected gene vectors. Biomacromolecules 11(7), 1802-1809 (2010).
36. Shmueli RB, Anderson DG, Green JJ. Electrostatic surface modifications to improve gene delivery. Expert Opin. Drug Deliv. 7(4), 535-550 (2010).
37. Lee LK, Williams CL, Devore D, Roth CM. Poly(propylacrylic acid) enhances cationic lipid-mediated delivery of antisense oligonucleotides. Biomacromolecules 7(5), 1502-1508 (2006).
38. Yoshihara C, Shew CY, Ito T, Koyama Y. Loosening of DNA/polycation complexes by synthetic polyampholyte to improve the transcription efficiency: effect of charge balance in the polyampholyte. Biophys. J. 98(7), 1257-1266 (2010).
39. Taratula O, Garbuzenko OB, Kirkpatrick P et al. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J. Control. Release 140(3), 284-293 (2009).
40. Russ V, Frohlich T, Li Y, Halama A, Ogris M, Wagner E. Improved in vivo gene transfer into tumor tissue by stabilization of pseudodendritic oligoethylenimine-based polyplexes. J. Gene Med. 12(2), 180-193 (2010).
41. Kusumoto K, Akita H, Ishitsuka T et al. A lipid envelope-type nano particle incorporating a multifunctional peptide for the systemic siRNA delivery to the pulmonary endothelium. ACS Nano 7(9), 7534-7541 (2013).
42. Jain S, Kumar S, Agrawal AK, Thanki K, Banerjee UC. Enhanced transfection efficiency and reduced cytotoxicity of novel lipid-polymer hybrid nanoplexes. Mol. Pharm. 10(6), 2416-2425 (2013).
43. Xue HY, Wong HL. Solid lipid-PEI hybrid nanocarrier: an integrated approach to provide extended, targeted, and safer siRNA therapy of prostate cancer in an all-in-one manner. ACS Nano 5(9), 7034-7047 (2011).
44. Hu CM, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl Acad. Sci. USA 108(27), 10980-10985 (2011).
45. Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc. Natl Acad. Sci. USA 104(39), 15549-15554 (2007).
46. Yamada Y, Hashida M, Hayashi Y et al. An approach to transgene expression in liver endothelial cells using a liposome-based gene vector coated with hyaluronic acid. J. Pharm. Sci. 102(9), 3119-3127 (2013).
47. Suzuki M, Takayanagi A, Shimizu N. Targeted gene delivery using humanized single-chain antibody with negatively charged oligopeptide tail. Cancer Sci. 95(5), 424-429 (2004).
48. Kurosaki T, Higuchi N, Kawakami S et al. Self-assemble gene delivery system for molecular targeting using nucleic acid aptamer. Gene 491(2), 205-209 (2012).
49. Sharma B, Peetla C, Adjei IM, Labhasetwar V. Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy. Cancer Lett. 334(2), 228-236 (2013).
50. Lee H, Lytton-Jean AK, Chen Y et al. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol. 7(6), 389-393 (2012).
51. Wang M, Thanou M. Targeting nanoparticles to cancer. Pharm. Res. 62(2), 90-99 (2010).
52. Chou ST, Leng Q, Scaria P, Woodle M, Mixson AJ. Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo. Cancer Gene Ther. 18(10), 707-716 (2011).
53. Muthu MS, Singh S. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine 4(1), 105-118 (2009).
54. Davis ME, Zuckerman JE, Choi CH et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464(7291), 1067-1070 (2010).
55. Heidel JD, Davis ME. Clinical developments in nanotechnology for cancer therapy. Pharm. Res. 28(2), 187-199 (2011).
56. Master AM, Sen Gupta A. EGF receptor-targeted nanocarriers for enhanced cancer treatment. Nanomedicine 7(12), 1895-1906 (2012).
57. Huang Y, Jiang Y, Wang H et al. Curb challenges of the 'Trojan Horse' approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Adv. Drug Deliv. Rev. 65(10), 1299-1315 (2013).
58. Said Hassane F, Saleh AF, Abes R, Gait MJ, Lebleu B. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell. Mol. Life Sci. 67(5), 715-726 (2010).
59. Bolhassani A. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochim. Biophys. Acta 1816(2), 232-246 (2011).
60. Tseng YC, Mozumdar S, Huang L. Lipid-based systemic delivery of siRNA. Adv. Drug Deliv. Rev. 61(9), 721-731 (2009).
61. Moore NM, Sheppard CL, Barbour TR, Sakiyama-Elbert SE. The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles. J. Gene Med. 10(10), 1134-1149 (2008).
62. Breuzard G, Tertil M, Goncalves C et al. Nuclear delivery of NFkB-assisted DNA/polymer complexes: plasmid DNA quantitation by confocal laser scanning microscopy and evidence of nuclear polyplexes by FRET imaging. Nucleic Acids Res. 36(12), e71 (2008).
63. Akita H, Masuda T, Nishio T, Niikura K, Ijiro K, Harashima H. Improving in vivo hepatic transfection activity by controlling intracellular trafficking: the function of GALA and maltotriose. Mol. Pharm. 8(4), 1436-1442 (2011).
64. Sun W, Davis PB. Reducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanism. J. Control. Release 146(1), 118-127 (2010).
65. Dash PR, Read ML, Fisher KD et al. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J. Biol. Chem. 275(6), 3793-3802 (2000).
66. Algar WR, Prasuhn DE, Stewart MH et al. The controlled display of biomolecules on nanoparticles: a challenge suited to bioorthogonal chemistry. Bioconjug. Chem. 22(5), 825-858 (2011).
67. Kim CH, Axup JY, Schultz PG. Protein conjugation with genetically encoded unnatural amino acids. Curr. Opin. Chem. Biol. 17(3), 412-419 (2013).
68. Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B. A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. ACS Nano 7(4), 2935-2947 (2013).
69. Bartlett DW, Davis ME. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bioconjug. Chem. 18(2), 456-468 (2007).
70. Ng QK, Sutton MK, Soonsawad P, Xing L, Cheng H, Segura T. Engineering clustered ligand binding into nonviral vectors: [alpha] v[beta]3 targeting as an example. Mol. Ther. 17(5), 828-836 (2009).
71. Stephanopoulos N, Francis MB. Choosing an effective protein bioconjugation strategy. Nat. Chem. Biol. 7(12), 876-884 (2011).
72. Hattori Y, Yamasaku H, Maitani Y. Anionic polymer-coated lipoplex for safe gene delivery into tumor by systemic injection. J. Drug Target. 21(7), 639-647 (2013).
73. Cheng CJ, Saltzman WM. Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides. Biomaterials 32(26), 6194-6203 (2011).
74. Jing F, Li J, Liu D, Wang C, Sui Z. Dual ligands modified double targeted nano-system for liver targeted gene delivery. Pharm. Biol. 51(5), 643-649 (2013).
75. Kluza E, van der Schaft DW, Hautvast PA et al. Synergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis. Nano Lett. 10(1), 52-58 (2010).
76. Li P, Liu D, Miao L et al. A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery. Int. J. Nanomed. 7, 925-939 (2012).
77. Khan M, Ong ZY, Wiradharma N, Attia AB, Yang YY. Advanced materials for co-delivery of drugs and genes in cancer therapy. Adv. Healthc. Mater. 1(4), 373-392 (2012).
78. Fleige E, Quadir MA, Haag R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv. Drug Deliv. Rev. 64(9), 866-884 (2012).
79. Bader AG. miR-34-a microRNA replacement therapy is headed to the clinic. Front. Genet. 3, 120 (2012).
80. Lammers T, Kiessling F, Hennink WE, Storm G. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J. Control. Release 161(2), 175-187 (2012).
81. Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR, Tsourkas A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338(6109), 903-910 (2012).
82. Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano 3(1), 16-20 (2009).
83. Ito T, Yoshihara C, Hamada K, Koyama Y. DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice. Biomaterials 31(10), 2912-2918 (2010).
84. Sakae M, Ito T, Yoshihara C et al. Highly efficient in vivo gene transfection by plasmid/PEI complexes coated by anionic PEG derivatives bearing carboxyl groups and RGD peptide. Biomed. Pharmacother. 62(7), 448-453 (2008).
85. Nishiyama N, Iriyama A, Jang WD et al. Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer. Nat. Mater. 4(12), 934-941 (2005).
86. Dvir T, Banghart MR, Timko BP, Langer R, Kohane DS. Photo-targeted nanoparticles. Nano Lett. 10(1), 250-254 (2010).
87. Chu DS, Johnson RN, Pun SH. Cathepsin B-sensitive polymers for compartment-specific degradation and nucleic acid release. J. Control. Release 157(3), 445-454 (2012).
88. Lehtinen J, Hyvonen Z, Subrizi A, Bunjes H, Urtti A. Glycosaminoglycan- resistant and pH-sensitive lipid-coated DNA complexes produced by detergent removal method. J. Control. Release 131(2), 145-149 (2008).